A new method for the Separation of alkaline phosphatase isoenzymes by means of high performance liquid chromatography (HPLC) is presented. One isoenzyme was identified in homogenate of small intestine, two were identified in bone, and two in liver, and fragment and biliary isoenzymes were identified in bile. Sera from 32 patients with different diseases of the skeletal System or the liver were analysed. High activities of the bone isoenzymes were detected in bone diseases, of the second liver isoenzyme in acute hepatitis and of the first liver and biliary isoenzymes in biliary obstruction. There are indications that the first liver isoenzyme is derived from the cell membrane and the second liver isoenzyme from the cytosol. The biliary isoenzyme is considered to be a highly sensitive and specific indicator for cholestasis. 
the most basic and the biliary the most acidic of all the known forms (5, 6) . Hitherto, the alkaline phosphatase isoenzymes have been measured by means of chemical inhibitors (7 -11) , heat inactivation (12) and different electrophoretical methods (13 -15) . Using immunological methods it is possible to differentiate between the isoenzyme groups of bone, liver, kidney and intestine or placenta (16, 17) . Nevertheless none of these methods is satisfactory for a precise differentiation of the bone from the liver isoenzyme, which represents the main diagnostic problem when alkaline phosphatase activities are pathologically elevated.
In the usual electrophoretic separations, the bone and liver isoenzymes overlap, owing to their similar pl's. These separations allow only a visual assesment of the relative proportions of isoenzymes. Also the heat inactivation and the chemical Inhibition methods only permit semiquantitative estimations. We describe a quick and reproducible method for a clear Separation of alkaline phosphatase isoenzymes by means of high Performance liquid chromatography (HPLC).
Methods
The Mono Q HR 5/5-column was equilibrated with 10ml l mol/1 Tris HC1 buffer pH 8.2 and 5 ml 20 mmol/1 Tris HC1 buffer pH 8.2 at a flow rate of l ml/min. Sera were centrifuged for five minutes at 8000g. Between one hundred and four hundred microlitres of serum were· diluted to l ml with 20 mmol/1 Tris HC1. The most precise separations were obtained with a sample volume of 100 . After application of the sample to the column, the isoenzymes were eluted stepwise with an LiCl-gradient (see fig. 1 ) at a flow rate of l ml/min. Fractions of 10 drops each were collected. After elution, remnants of protein were removed from the column with l ml of l mol/1 NaCl. The enzyme activity was constantly measured in 100 fractions. A Substrate concentration of 5 mmol/14-nitrophenylphosphate in 0.5 mol/1 diethanolamine hydrochloride pH 9.8 and in the presence of 0.5 mmol/1 MgCl 2 gave a zero order reaction of isoenzyme activity at 25 °C during the measurement period of two minutes.
Homogenates of liver, small intestine and vertebral spongiosa were used for the Identification of isoenzymes. Tissues obtained within 24 hours post mortem from adult patients were homogenized in 20 mmol/1 Tris/HCl buffer pH 8.2, then frozen and thawed three times. After centrifugation for 15 minutes at 8000 g interfering lipids were removed with Freon. Bile drained from postcholecystectomy patients was collected and tised for the identification öf the biliary isoenzyme. The serum fröm patients with transient hyperphosphatasaemia was heated for 15 minutes at 56 °C to demonstrate the different heat stabilities of the separäted isoenzymes. Isolated isoenzyme fractions were treated with 5 mmol/1 Z,-phenylalanine.
Materials and Methods

Materials
For the HPLC-separation, a Gilson Model 302 pump (Abimed, Düsseldorf, FRG) was used. The gradient was formed by a 11300 ultrograd gradient mixer (LKB, Bromma, Sweden). For the Chromatographie separations, Pharmacia prepacked Mono Q HR 5/5 (5 mm 50 mm) columns (Uppsala, Sweden) were used; these consist of a strong anion exchanger, the charged group on the gel being -CH 2 -N(CH 3 )3". Diethanolamine was obtained from Fluka (Buchs, Switzerland); Tris, HC1, LiCl, 4-nitrophenyl phosphate and L-phenylalanine, p. a. grade, from E. Merck (Darmstadt, FRG).
Results
The sequence of the eluted alkaline phosphatase isoenzymes is shown in figure 2. Standard deviatioii of the peak maximum is s = ±2 fractions. The isoenzyme of small intestine jvas eluted first at a LiCl concentration of 90 mmol/1. In some separations this isoenzyme overlapped with the first of the bone isozymes. This overlap is demonstrated in the sertun eluate of a patient with osteomyelitis. Thereafter the second isoenzyme of bone was eluted by 105 mmol/1 LiCl. In sera we could generally identify two liver isoenzymes. In liver extracts, however, only a small activity of the rst liver isoenzyme, eluted by 105 mmol/1 LiCl, was detected. The second liver isoenzyme was eluted by 130 mmol/1 LiCl. The main bile fraction fbllowed at LiCl concentrations between 185 -230 mmol/1. In addition, p to four isoenzyme peaks were counted between the second liver isoenzyme and the biliary isoenzyme; we named these fragment isoenzymes. By heat inactivation, 95% of bone and 75% of liver isoenzyme activity were inactivated. Under treatment with 5 mmol/1 JL-phenylalanine, 80% of small intestine, 13% and 12% of bone, and 14% and 16% of liver isoenzyme activity were inhibited.
Case Reports
Sera from 32 patients with several types of hepatitis (n = 8), cholestasis (n = 6), liver cirrhosis (n = 6), several bone tumours (n == 5), phosphate diabetes (n = 1), rickets (n = 1), osteomyelitis (n = 2) and transient hyperphosphatasaemia (n = 3) were examined and compared with healthy controls (n = 15).
Different isoenzyme patterns were found at different stages of development ( fig. 3 ). For instance, the isoenzyme pattern of a new-born phild is characterized by high activities of the liver isoenzymes. During infancy the bone isoenzymes become predominant. After the growth period of infancy the isoenzymes of liver remain, while the activities of the bone forms decrease.
The distribution of the isoenzyme activities in bone diseases is presented in figure 4 . Separation 9 from a male infant with phosphate diabetes shows an increased activity of the bone isoenzyme. Separations 10 and 11 show* isoenzyme activities in a case of osteosarcoma before and after 50 days therapy with platinex, adriamycin and methotrexate. As a result of the cytostatic therapy, the activities of bone isoenzymes were reduced. Figure 5 shows the isoenzyme activities in cases of hepatitis and cholestasis. In all examined cases of hepatitis it was demonstrated that the second liver isoenzyme represents the major part of the total alkai line phosphatase activity. Separation 13 shows the 90 appearance of the biliary isoenzyme during cholestasis. In this case the isoenzyme activities from a 20 year-old male patient re sh wn, whose liver was infiltrated by hydatid cysts. The same patient | developed cholestasis s a consequence of acute pan-90 creatitis. The rise of the total alkaline phosphatase activity was mainly produced by the increase of the first liver isoenzyme and the appearance of the biliary isoenzyme. Our analysis of three patients with transient hyperphosphatasaemia (data not shown) shows that the activities of all described isoenzymes were elevated, but the biliary isoenzyme was not detectable.
Discussion
Measurement of the activity of alkaline phosphatase plays an important role in clinical-chemical diagnosis, but its usefulness is limited, because the total activity is composed of several individual isoenzyme activities. Particulärly the Interpretation of total alkaline phosphatase activity in paediatric patients is very difficult. The wide ränge of normal values in the individual age groups makes it difficult to define pathological activities of alkaline phosphatase. Determination of isoenzyme activities becomes essential, especially in cases of uncertainty. As demonstrated in figure 6 in combined liver and bone diseases, the total activity of alkaline phosphatase can only be conclusive when the activities of isoenzymes are known. By separating the isoenzymes, the cause of the increase of alkaline phosphatase activity can be determined. This example illustrates that the Separation of alkaline phosphatase isoenzymes is a valuable method fpr diagnosis and therapy control in diseases of liver and bone. This method makes it possible to reduce the scale of additional diagnostics (measürement of other liver enzymes, calcium, phosphate, parathyrin and radiodiagnosis).
In accordance with our results, Johnson et al. ideiitified two bone isoenzymes by electrophoresis in polyacrylamide (18) . Their results confirm the overlap of the small intestine isoenzyme with the first bone isoenzyme. They called the first bone isoenzyme "Growth AP".
Walker et al. fpund two isoenzymes in liver, which they called "slow-" and "fast liver" (19) . Crofton et al. used ion exchange chromatography tp separate the biliary isoenzyme. They named it "High Mplecular Weight Alkaline Phosphatase" (20) . The isoenzymes which are characterized in the literature are cpmparable to the isoenzymes of our Separation method, except for those we call "fragment isoenzymes". Hitherto no such alkaline phosphatase isoenzymes have been described. The behaviour of the first and second liver isoenzymes is of special interest. Highest activities of the second liver isoenzyme were found in cases of hepatitis. On the other-hand, elevations of the first liver isoenzyme and the biliary isoenzyme were characteristical of cholestasis. There is evidence in the literature that the first liver isoenzyme is part of the liver cell membrane and is removed by bile acids which accumulate during cholestasis. Schlaeger et al. demonstrated that the alkaline phosphatase äs well äs other membrane-bound enzymes are more soluble if the concentration of bile acids is increased (23) . The second liver isoenzyme seems to be localized in the cytosol. Like other cytosolic enzymes it shows high serum activities during various forms of cell damage, such äs hepatitis. Our supposition corresponds to the results of Simon et al., who showed that alkaline phosphatase is localized at the membrane äs well äs in the cytosol of the rat liver cell (24) . In addition they demonstrated that the membrane-bound alkaline phosphatase activity is increased in bile duct obstruction, while the cytosolic alkaline phosphatase remained unaltered. The importance of the biliary isoenzyme for the diagnosis of cholestasis is known. In 111 out of 123 cases of cholestasis, Siede et al. demonstrated that the serum biliary isoenzyme is a highly specific and sensitive indicator for cholestasis (25) . Its specifity äs an indicator for cholestasis was even higher than that of LP X. De Broe characterized the biliary isoenzyme äs a vesicle originating from fragments of the liver cell membrane during cholestasis (26) . Our own results showed it to be present in two cases of congenital occlusion of the bile duct. However both represented advanced cases with already existing biliary cirrhosis. It will be of interest to find whether this method is able to discriminate between congenital atresia of the bile duct and hepatitis of the newborn.
The advantage of our method for separating the isoenzymes of alkaline phosphatase is its precision. This method improves the diagnostic value of the alkaline phosphatase determination. Moreover it allows the clarification of problems of differential diagnosis in liver and böne diseases.
